Vertex Pharmaceuticals Incorporated
Market Cap
$134.2B
Global Rank
#126
All-Time High
$134.4B
2026-07-06
Total Growth
+0%
since 2026
Market Cap Context
- Larger than 66% of the 367 companies we track (globally).
- Equivalent to 0.4% of United States's GDP (2025 data).
- Just above: #125 HDFC Bank Limited ($134.8B)
- Just below: #127 Chubb Limited ($133.9B)
- Best year: 2000 (+309%). Worst year: 2001 (-66%).
Vertex Pharmaceuticals Incorporated Financial Breakdown (FY 2025)
Source: Yahoo Finance โ VRTX annual filings (2025) โ$12.0B revenue ยท $4.6B operating income ยท $4.0B net income
- โOperating margin: 37.9% on $12.0B in revenue.
- โR&D is 33.7% of revenue ($4.0B).
- โNet income margin: 32.9% โ $4.0B in profit.
- โFree cash flow: $3.2B (26.6% of revenue).
Cost / Operating Expenses
Total operating expenses $7.4B
Total
$7.4B
Capital Expenditures
$0.4B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$3.2B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
Vertex Pharmaceuticals Incorporated Market Cap History (2026โ2026)
Vertex Pharmaceuticals Incorporated vs Sector Peers by Market Cap
Compare Vertex Pharmaceuticals Incorporated
Ranking History
| Year | Market Cap | Rank | YoY Change |
|---|---|---|---|
| 2026 | $134.2B | #126(โ10) | +16.7% |
| 2025 | $115.1B | #136(โ7) | +12.6% |
| 2024 | $102.2B | #129(โ21) | -1.0% |
| 2023 | $103.3B | #108(โ17) | +40.9% |
| 2022 | $73.3B | #125(โ57) | +31.5% |
| 2021 | $55.7B | #182(โ39) | -7.1% |
| 2020 | $60.0B | #143(โ18) | +7.9% |
| 2019 | $55.6B | #125(โ3) | +32.1% |
| 2018 | $42.1B | #128(โ24) | +10.6% |
| 2017 | $38.0B | #152(โ70) | +103.4% |
| 2016 | $18.7B | #222(โ94) | -41.5% |
| 2015 | $31.9B | #128(โ2) | +5.9% |
| 2014 | $30.2B | #130(โ44) | +59.9% |
| 2013 | $18.9B | #174(โ28) | +77.3% |
| 2012 | $10.6B | #202 | +26.2% |
| 2011 | $8.4B | #202(โ4) | -5.2% |
| 2010 | $8.9B | #206(โ37) | -18.2% |
| 2009 | $10.9B | #169(โ4) | +41.0% |
| 2008 | $7.7B | #165(โ62) | +30.8% |
| 2007 | $5.9B | #227(โ49) | -37.9% |
| 2006 | $9.5B | #178(โ9) | +35.2% |
| 2005 | $7.0B | #187(โ43) | +161.8% |
| 2004 | $2.7B | #230(โ16) | +2.1% |
| 2003 | $2.6B | #214(โ54) | -34.7% |
| 2002 | $4.0B | #160(โ22) | -35.5% |
| 2001 | $6.2B | #138(โ69) | -65.6% |
| 2000 | $18.1B | #69(โ51) | +308.6% |
| 1999 | $4.4B | #120(โ2) | +17.6% |
| 1998 | $3.8B | #118(โ14) | -9.8% |
| 1997 | $4.2B | #104(โ35) | -18.0% |
| 1996 | $5.1B | #69(โ9) | +51.9% |
| 1995 | $3.4B | #78(โ1) | +76.7% |
| 1994 | $1.9B | #79 |
Other Healthcare Companies
FAQ
What is Vertex Pharmaceuticals Incorporated's market cap?
Vertex Pharmaceuticals Incorporated (VRTX) has a market capitalization of $134.2B, making it the #126 largest company in the world by market cap.
What was Vertex Pharmaceuticals Incorporated's highest market cap?
Vertex Pharmaceuticals Incorporated's all-time high market cap was $134.4B, reached in 2026-07-06. Its highest rank was #126 in 2026.
What sector is Vertex Pharmaceuticals Incorporated in?
Vertex Pharmaceuticals Incorporated is in the Healthcare sector, specifically the Biotechnology industry. It is based in United States.
How has Vertex Pharmaceuticals Incorporated's market cap changed over time?
Vertex Pharmaceuticals Incorporated has been tracked since 2026. Its market cap has grown by 0% from $134.2B in 2026 to $134.2B today.